We live in a world posing many new and different challenges for human health, and one such challenge is the rapidly expanding number of cases of human neurodegenerative disease. Many of the most common neurodegenerative diseases are dementias affecting cognitive and behavioural functions, and it is very concerning that treatment options remain extremely limited. The unmet medical needs for many conditions are extremely high because, unlike many of the other common non-communicable diseases (NCDs), such as cardiovascular diseases, cancers and diabetes, few disease-modifying therapies exist. The causes are multifactorial and the potential disease drivers are numerous. Aside from the rising age profile of the global population and the known genetic risk factors, there are many potential modifiable risk factors, ranging from hypertension, obesity, hearing loss, smoking, depression, physical inactivity, social isolation, diabetes and years of education [1]. The progressive and terminal nature of these conditions places a considerable personal burden on the individual affected. Additionally, there is a growing economic and public health burden, forcing governments and health services to make difficult choices concerning the allocation of medical resources. Tens of millions of people are indiscriminately affected by various dementias, which are rising at an alarming rate [2] .
Metabolites 2019, 9, 283 2 of 2 Cerebral palsy (CP) and age-related macular degeneration (AMD), but also includes conditions such as traumatic brain injury (TBI) and transient ischemic attacks (TIA). Within the research articles, metabolomic methods include 1 H NMR, direct injection liquid chromatography-tandem mass spectrometry (DI/LC-MS/MS), gas chromatography-mass spectrometry (GC-MS) and LC-MS following perfusion with 13 C-labelled compounds. There are also reviews of the different method types that can be utilised in neurodegenerative disease research, including imaging mass spectrometry (IMS) and direct mass spectrometry-based approaches. Finally, the articles feature the analysis and review of data from clinical samples, various rodent models and also more fundamental models such as C. elegans.
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